Please select the option that best describes you:
Topics:
Gynecologic Cancers • Medical Oncology
What is your preferred systemic regimen for MMR-proficient, high-grade endometrial cancer that recurs <1 year from adjuvant carboplatin/paclitaxel?
Assuming a good performance status, do you turn next to lenvatinib/pembrolizumab, liposomal doxorubicin +/- avastin, or something else?